𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NO induced apoptosis of vascular smooth muscle cells accompanied by ceramide increase

✍ Scribed by Cyril M. Pilane; Edward F. LaBelle

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
218 KB
Volume
199
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We have shown previously that nitric‐oxide (NO) can induce apoptosis of vascular smooth muscle cells (VSMCs) and that the NO‐induced apoptosis is accompanied by an increase in arachidonic acid release via cytoplasmic Ca^2+^‐dependent phospholipase A~2~ (cPLA~2~). We have evidence that during NO‐induced apoptosis there is an increase in ceramide synthesis. The use of inhibitors of ceramide synthesis, namely, fumonisin B1 and desipramine, which block ceramide synthase and sphingomyelinase, respectively revealed that the ceramide was produced via the sphingomyelinase pathway. Inhibition of acid sphingomyelinase by desipramine was shown to inhibit NO‐induced apoptosis while fumonisin B1 failed to inhibit this process. C~2~‐ceramide could induce apoptosis in cultured VSMCs. Apoptosis in smooth muscle cells was accompanied by the increased activity of DNA fragmentation factor‐40 and the secretion of cathepsin D from the cells. In this study, ceramide appears to function as a mediator of apoptosis. J. Cell. Physiol. 199: 310–315, 2004© 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Arachidonic acid release by cPLA2 may be
Arachidonic acid release by cPLA2 may be causally related to NO-induced apoptosis in vascular smooth muscle cells
✍ Cyril M. Pilane; Edward F. LaBelle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Apoptosis has been shown to occur in vascular smooth muscle cells during the development of atherosclerosis. In order to investigate the possible role of arachidonic acid during apoptosis in vascular smooth muscle, we induced apoptosis in cultured rat aortal smooth muscle cells (SMCs) b

cPLA2 activator peptide, PLAP, increases
cPLA2 activator peptide, PLAP, increases arachidonic acid release and apoptosis of vascular smooth muscle cells
✍ Cyril M. Pilane; Edward F. LaBelle 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract Apoptosis of vascular smooth muscle cells (VSMCs) has recently drawn a lot of interest in various laboratories due to its importance in atherogenesis. We have shown previously that nitric‐oxide (NO) can induce apoptosis of VSMCs and that the NO‐induced apoptosis is accompanied by an inc

Nitric oxide stimulated vascular smooth
Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids
✍ Cyril M. Pilane; Edward F. LaBelle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract The role of eicosanoids in atherogenesis has not been thouroughly explained. This is partly due to the numerous eicosanoids and the variable effects that each has on different systems. Apoptosis of vascular smooth muscle cells has been shown to play a role in the atherosclerotic disease

Statins inhibit in vitro calcification o
Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators
✍ Akane Kizu; Atsushi Shioi; Shuichi Jono; Hidenori Koyama; Yasuhisa Okuno; Yoshik 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract Although lipid‐lowering therapy with 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) decreases the progression of coronary artery and aortic valve calcification, the mechanism of action of these drugs to inhibit the calcification process remains unclear. In this stu

Differential processing of osteopontin c
Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine
✍ Alan R. Parrish; Kenneth S. Ramos 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Repeated cycles of vascular injury by allylamine induce vascular lesions similar to those seen in atherosclerotic vessels, or following balloon catheterization. Vascular (aortic) smooth muscle cells harvested from allylamine-treated animals (i.e., allylamine cells) acquire a proliferative advantage

Inhibition of apoptosis and caspase-3 in
Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1
✍ Yabing Chen; Robert J. Kelm Jr.; Ralph C. Budd; Burton E. Sobel; David J. Schnei 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

## Abstract Increased expression of plasminogen activator inhibitor type 1 (PAI‐1) is associated with decreased apoptosis of neoplastic cells. We sought to determine whether PAI‐1 alters apoptosis in vascular smooth muscle cells (VSMC) and, if so, by what mechanisms. A twofold increase in the expre